The potential application of chlorin e6–polyvinylpyrrolidone formulation in photodynamic therapy

Photochemical and Photobiological Sciences

Volumn 5, Issue 11, 2006, Pages 1031-1037

  Chin, William Wei Lim ^a   Heng, Paul Wan Sia ^b   Bhuvaneswari, Ramaswamy ^a   Lau, Weber Kam On ^c   Olivo, Malini ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIN E6; PHOTOSENSITIZING AGENT; POVIDONE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG FORMULATION; FLUORESCENCE; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR; TUMOR NECROSIS;

MUS MUSCULUS;

EID: 33750561496     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b605772a     Document Type: Article

References (38)

1. D. E. Dolmans D. Fukumura R. K. Jain Photodynamic therapy for cancer Nat. Rev. Cancer 2003 3 380-7.
2. M. Olivo W. Chin Perylenequinones in Photodynamic Therapy: Cellular versus Vascular Response J. Environ. Pathol. Toxicol. Oncol. 2006 25 223-38.
3. B. Cunderlikova L. Gangeskar J. Moan Acid–base properties of chlorin e6: relation to cellular uptake J. Photochem. Photobiol., B 1999 53 81-90.
4. A. Colasanti A. Kisslinger D. Kusch R. Liuzzi M. Mastrocinque F. P. Montforts M. Quarto P. Riccio G. Roberti F. Villani In vitro photo-activation of newly synthesized chlorin derivatives with red-light-emitting diodes J. Photochem. Photobiol., B 1997 38 54-60.
5. R. Bachor C. R. Shea R. Gillies T. Hasan Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres Proc. Natl. Acad. Sci. U. S. A. 1991 88 1580-4.
6. U. Schmidt-Erfurth H. Diddens R. Birngruber T. Hasan Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates Br. J. Cancer 1997 75 54-61.
7. S. K. Bisland D. Singh J. Gariepy Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles Bioconjugate Chem. 1999 10 982-92.
8. A. Gijsens L. Missiaen W. Merlevede P. de Witte Epidermal growth factor-mediated targeting of chlorin e6 selectively potentiates its photodynamic activity Cancer Res. 2000 60 2197-202.
9. B. Pegaz E. Debefve F. Borle J. P. Ballini G. Wagnieres S. Spaniol V. Albrecht D. Scheglmann N. E. Nifantiev H. van den Bergh Y. N. Konan Preclinical evaluation of a novel water-soluble chlorin E6 derivative. (BLC 1010) as photosensitizer for the closure of the neovessels Photochem. Photobiol. 2005 81 1505-10.
10. Y. Namiki T. Namiki M. Date K. Yanagihara M. Yashiro H. Takahashi Enhanced photodynamic antitumor effect on gastric cancer by a novel photosensitive stealth liposome Pharmacol. Res. 2004 50 65-76.
11. J. Kopecek P. Kopeckova T. Minko Z. R. Lu C. M. Peterson Water soluble polymers in tumor targeted delivery J. Controlled Release 2001 74 147-58.
12. M. R. Hamblin J. L. Miller I. Rizvi B. Ortel E. V. Maytin T. Hasan Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer Cancer Res. 2001 61 7155-62.
13. M. R. Hamblin J. L. Miller I. Rizvi H. G. Loew T. Hasan B. Ortel E. V. Maytin Pegylation of charged polymer–photosensitiser conjugates: effects on photodynamic efficacy Br. J. Cancer 2003 89 937-43.
14. J. G. Shiah Y. Sun C. M. Peterson R. C. Straight J. Kopecek Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments Clin. Cancer Res. 2000 6 1008-15.
15. D. Le Garrec S. Gori L. Luo D. Lessard D. C. Smith M. A. Yessine M. Ranger J. C. Leroux Poly(N-vinylpyrrolidone)-block-poly(D, L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation J. Controlled Release 2004 99 83-101.
16. B. Ramaswamy V. Manivasager W. W. Chin K. C. Soo M. Olivo Photodynamic diagnosis of a human nasopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon Int. J. Oncol. 2005 26 1501-6.
17. W. W. Chin W. K. Lau R. Bhuvaneswari P. W. Heng M. Olivo Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone J. Photochem. Photobiol., B 2006 84 2 103-10.
18. W. W. Chin W. K. Lau R. Bhuvaneswari P. W. Heng M. Olivo Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model Cancer Lett. 2006 10.1016/j.canlet.2005.12.041.
19. W. Zheng M. Olivo K. C. Soo The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo Int. J. Cancer 2004 110 295-300.
20. D. Zaak D. Frimberger H. Stepp S. Wagner R. Baumgartner P. Schneede M. Siebels R. Knuchel M. Kriegmair A. Hofstetter Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection J. Urol. 2001 166 1665-8; discussion 1668-9.
21. G. A. Kostenich I. N. Zhuravkin E. A. Zhavrid Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors J. Photochem. Photobiol., B 1994 22 211-7.
22. M. V. Parkhots V. N. Knyukshto G. A. Isakov P. T. Petrov S. V. Lepeshkevich A. Y. Khairullina B. A. Dzhagarova Spectral-luminiescent studies of the “Photolon” photosensitizer in model media and in blood of oncological patients J. Appl. Spectrosc. 2003 70 921-6.
23. R. K. Chowdhary I. Sharif N. Chansarkar D. Dolphin L. Ratkay S. Delaney H. Meadows Correlation of photosensitizer delivery to lipoproteins and efficacy in tumor and arthritis mouse models; comparison of lipid-based and Pluronic P123 formulations J. Pharm. Pharm. Sci. 2003 6 198-204.
24. Y. Yoshioka Y. Tsutsumi Y. Mukai H. Shibata T. Okamoto Y. Kaneda S. Tsunoda H. Kamada K. Koizumi Y. Yamamoto Y. Mu H. Kodaira K. Sato-Kamada S. Nakagawa T. Mayumi Effective accumulation of poly(vinylpyrrolidone-co-vinyl laurate) into the spleen J. Biomed. Mater. Res. A 2004 70 219-23.
25. Y. Kaneda Y. Tsutsumi Y. Yoshioka H. Kamada Y. Yamamoto H. Kodaira S. Tsunoda T. Okamoto Y. Mukai H. Shibata S. Nakagawa T. Mayumi The use of PVP as a polymeric carrier to improve the plasma half-life of drugs Biomaterials 2004 25 3259-66.
26. H. Maeda T. Sawa T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Controlled Release 2001 74 47-61.
27. L. S. Taylor G. Zografi Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions Pharm. Res. 1997 14 1691-8.
28. A. B. Uzdensky D. E. Bragin M. S. Kolosov A. Kubin H. G. Loew J. Moan Photodynamic effect of hypericin and a water-soluble derivative on isolated crayfish neuron and surrounding glial cells J. Photochem. Photobiol., B 2003 72 27-33.
29. A. Ferrario D. Kessel C. J. Gomer Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model Cancer Res. 1992 52 2890-3.
30. K. Saito N. Mikuniya K. Aizawa Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect Jpn. J. Cancer Res. 2000 91 560-5.
31. S. W. Taber V. H. Fingar C. T. Coots T. J. Wieman Photodynamic therapy using mono-L-aspartyl chlorin e6. Npe6) for the treatment of cutaneous disease: a Phase I clinical study Clin. Cancer Res. 1998 4 2741-6.
32. E. Maugain S. Sasnouski V. Zorin J. L. Merlin F. Guillemin L. Bezdetnaya Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes Oncol. Rep. 2004 12 639-45.
33. B. Cunderlikova M. Kongshaug L. Gangeskar J. Moan Increased binding of chlorin e(6) to lipoproteins at low pH values Int. J. Biochem. Cell Biol. 2000 32 759-68.
34. X. Zhou B. W. Pogue B. Chen E. Demidenko R. Joshi J. Hoopes T. Hasan Pretreatment photosensitizer dosimetry reduces variation in tumor response Int. J. Radiat. Oncol., Biol., Phys. 2006 64 1211-20.
35. P. Qian J. F. Evensen C. Rimington J. Moan A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice Cancer Lett. 1987 36 1-10.
36. C. J. Gomer A. Ferrario Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model Cancer Res. 1990 50 3985-90.
37. A. L. Chan M. Juarez R. Allen W. Volz T. Albertson Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6. NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces Photodermatol. Photoimmunol. Photomed. 2005 21 72-8.
38. H. Kato K. Furukawa M. Sato T. Okunaka Y. Kusunoki M. Kawahara M. Fukuoka T. Miyazawa T. Yana K. Matsui T. Shiraishi H. Horinouchi Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung Lung Cancer 2003 42 103-11.